The Garvan Institute of Medical Research Feed

The Garvan Institute of Medical Research

Microscopic staining image showing kidney cells

Rare variants of an inflammation 'brake' gene may help reveal outcomes of kidney disease

24 Apr 2023

A gene that controls inflammation could pave the way for more precise disease diagnostics and personalised treatments for kidney disease. 

Microscopic image of a tumour

Exposing tumours to bacteria converts immune cells to cancer killers

14 Mar 2023

New research on inflammation could lead to better treatments to improve outcomes for people with advanced or previously untreatable cancers. 

DNA double helix. Genetic cancer risk.

Global study identifies genes that cause sarcoma

20 Jan 2023

Understanding the genetic basis of sarcoma will allow earlier detection and better guide treatment. 

Justin Gooding

UNSW professor wins prestigious Frontiers Research Award

12 Dec 2022

Professor Justin Gooding and Dr Deborah Burnett have been recognised in the Annual Health and Medical Research Awards for their outstanding achievements in health and medical innovation.

Third booster shot what next?

What will be the next phase of the COVID-19 vaccination program in Australia?

23 Feb 2022

We’ve had the third COVID-19 booster rollout. Is a fourth booster on the cards? 

Professor Paul Timpson; Professor David Thomas; Associate Professor Phoebe Phillips and Professor David Goldstein; and Associate Professor Marina Pajic.

Pancreatic cancer clinical trial program to target genome and scar tissue

25 Feb 2021

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.